Screener
Kestra Medical Technologies KMTS Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Kestra Medical Technologies in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Kestra Medical Technologies’s 10-Q, filed September 14, 2026.
- Filed
- Sep 14, 2026, 5:15 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q3 2026
- Accession
- 0001193125-26-390766
| Line item | Three Months Ended July 31, 2026 | Three Months Ended July 31, 2025 |
|---|---|---|
| Revenue | $30,971 | $19,371 |
| Cost of revenue | 13,473 | 10,520 |
| Gross profit | 17,498 | 8,851 |
| Operating expenses: | ||
| Research and development | 6,796 | 4,001 |
| Selling, general and administrative | 48,359 | 33,728 |
| Total operating expenses | 55,155 | 37,729 |
| Loss from operations | (37,657) | (28,878) |
Item 1. Financial Statements.
FAQ
- What is Kestra Medical Technologies's total revenue?
- Kestra Medical Technologies (KMTS) reported total revenue of $30.97M in Q2 2026.
- How has Kestra Medical Technologies's total revenue changed year-over-year?
- Kestra Medical Technologies's total revenue increased by 59.9% year-over-year, from $19.37M to $30.97M.
- What is the long-term trend for Kestra Medical Technologies's total revenue?
- Over 2 years (2024 to 2026), Kestra Medical Technologies's total revenue has grown at a 84.9% compound annual growth rate (CAGR), from $27.81M to $95.13M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Kestra Medical Technologies's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude